Populations are ageing worldwide, with considerable time lived in ill-health, putting upwards
pressure on healthcare budgets. Healthy ageing is defined as maintaining functional ability …

There is emerging evidence that the live herpes zoster (shingles) vaccine might protect
against dementia. However, the existing data are limited and refer only to the live vaccine …

Alzheimer's disease is increasing in prevalence disproportionately to longevity, placing
enormous burden on individuals, families, healthcare systems and the economy …

INTRODUCTION Relationships and interplay of an infection burden (IB) and periodontal
pathogens or periodontal disease (Pd) markers with Alzheimer's disease (AD) and all‐cause …

There is growing awareness that infections may contribute to the development of senile
dementia including Alzheimer's disease (AD), and that immunopotentiation is therefore a …

Background Herpes zoster (HZ), commonly known as “shingles,” may contribute to cognitive
decline through mechanisms such as neuroinflammation or direct neuronal injury. However …

Background It is unclear whether inactivated influenza vaccination (IIV) or pneumococcal
vaccination are associated with the risk of dementia; however, both types of vaccination are …

The strategy for the development of new drugs for Alzheimer's disease (AD) recognizes that
an effective therapy requires early therapeutic intervention and a multifactorial approach that …

The varicella zoster virus, a neurotropic herpesvirus, has been hypothesized to play a role in
the pathophysiology of dementia, such as through neuroinflammatory processes or …

Background Herpes zoster is a potential risk factor for dementia. The effectiveness of the
recombinant zoster vaccine for preventing dementia is uncertain. Methods This retrospective …